Word

GENIXUS

Status

Dead

Status Code

606

Status Date

Monday, March 25, 2024

Serial Number

90337589

Mark Type

4000

Filing Date

Monday, November 23, 2020

Published for Opposition

Tuesday, December 28, 2021

Abandoned Date

Monday, March 25, 2024

Trademark Owner History

Genixus, Corp. - Owner At Publication

Classifications

40 Contract manufacturing of pharmaceutical products; Contract manufacturing of pre-filled syringes containing pharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations

5 Pharmaceutical preparations and substances for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Injectable pharmaceuticals for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pre-filled syringes containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith

42 Pharmaceutical research services; Research and development of pharmaceutical products; Scientific research in the field of pharmacy; Scientific research into the development of new products, namely pharmaceutical preparations; Testing services for assessing the efficacy and safety of pharmaceuticals; Development of products, namely pharmaceutical preparations; Scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; Industrial analysis and research services in the field of pharmaceuticals

Trademark Events

Mar 25, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 25, 2024

Abandonment - No Use Statement Filed

Feb 29, 2024

Withdrawal Of Attorney Granted

Feb 29, 2024

Teas Withdrawal Of Attorney Received

Aug 22, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 18, 2023

Sou Extension 3 Granted

Aug 18, 2023

Sou Extension 3 Filed

Aug 18, 2023

Sou Teas Extension Received

Jan 27, 2023

Notice Of Approval Of Extension Request E-Mailed

Jan 25, 2023

Sou Extension 2 Granted

Jan 25, 2023

Sou Extension 2 Filed

Jan 25, 2023

Sou Teas Extension Received

Aug 13, 2022

Notice Of Approval Of Extension Request E-Mailed

Aug 11, 2022

Sou Extension 1 Granted

Aug 11, 2022

Sou Extension 1 Filed

Aug 11, 2022

Sou Teas Extension Received

Feb 22, 2022

Noa E-Mailed - Sou Required From Applicant

Dec 28, 2021

Official Gazette Publication Confirmation E-Mailed

Dec 28, 2021

Published For Opposition

Dec 8, 2021

Notification Of Notice Of Publication E-Mailed

Nov 23, 2021

Approved For Pub - Principal Register

Nov 13, 2021

Teas/Email Correspondence Entered

Nov 12, 2021

Correspondence Received In Law Office

Nov 12, 2021

Teas Response To Office Action Received

May 13, 2021

Notification Of Non-Final Action E-Mailed

May 13, 2021

Non-Final Action E-Mailed

May 13, 2021

Non-Final Action Written

May 6, 2021

Assigned To Examiner

Jan 28, 2021

New Application Office Supplied Data Entered

Nov 26, 2020

New Application Entered